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Introduction. In 2007 in Italy, the National Institute of Health 
published a new protocol for the National Surveillance of Invasive 
Bacterial Diseases, in order to enhance the notification system of 
these diseases and to improve immunization strategies. Available 
vaccines to prevent these diseases were introduced for the first 
time into the 1999-2000 National Immunization Plan (NIP) (vac-
cination against Haemophilus influenzae type b) and the 2005-
2007 NIP (vaccination against Streptococcus pneumoniae and 
Neisseria meningitidis serogroup C).
We evaluated the frequency of invasive diseases, on the basis of the 
number of notifications, the different immunization strategies in 
the Italian Regions and the vaccination coverage in Local Health 
Agency 4 “Chiavarese” (LHA) in the Liguria Region (Italy).
Materials and methods. We evaluated the number of notifica-
tions of invasive diseases collected by the national databank coor-
dinated by the ISS (Informative System of Infectious Diseases, 
SIMI) from 1994 to 2011. We also examined regional regulations 
concerning immunization policies. Immunization coverage was 
calculated by means of the “OASIS” software (version 9.0.0) used 
in our LHA.
Results and discussion. Available data indicate that the large-
scale vaccination policy begun in 1999 in Italy has led to a great 
reduction in Haemophilus influenzae-related diseases in the 
pediatric age. Meningococcal diseases have declined to a lesser 
degree; this is due to the more recent introduction of vaccination 
against serogroup C (in 2005), the variability of the immuniza-
tion strategies adopted in the different Italian Regions and the 
availability of the vaccination against serogroup C only in the 
pediatric age. The diseases caused by Streptococcus pneumoniae 
seem to have increased since 2007 because of the implementation 
of the Surveillance of Invasive Diseases Program and the subse-
quent notification of all invasive diseases (not only meningitis). 
Furthermore, the various Italian Regions have adopted different 
immunization strategies against this disease, too. 
We evaluated vaccination coverage in LHA 4 from 2003 to 2008. 
VC levels against Haemophilus influenzae are excellent; the 
objective indicated in the 2005-2007 NIP (≥ 95%) has therefore 
been reached. Vaccination coverage levels against Streptococcus 
pneumoniae and Neisseria meningitidis serogroup C at the 24th 
month of age are also good. However, we need to implement spe-
cific immunization strategies for adolescents, since the vaccina-
tion coverage levels are not completely satisfactory. 
Conclusions. The improvement of the national invasive disease 
surveillance system has provided better knowledge of the size 
of the problem and the impact of immunization strategies on the 
incidence of invasive bacterial diseases. 
Furthermore, immunization policies in Italy display territorial 
heterogeneity. Vaccination coverage levels against Haemophilus 
influenzae, Streptococcus pneumoniae and Neisseria meningi-
tidis at the 24th month in LHA 4 are very high. In adolescents (15 
year-olds) the immunization coverage are good but needs to be 
improved through specific strategies, such as raising the aware-
ness of healthcare workers, involving general practitioners and 
educating the target population.
The full article is free available on www.jpmh.org
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Summary
Introduction
Neisseria meningitidis, Haemophilus influenzae type b 
and Streptococcus pneumonia are bacteria that cause se-
rious invasive infections such as meningitis, sepsis and 
pneumonia with bacteremia [1]. These diseases are a 
major cause of morbidity and mortality, and carry high 
rates of complications [2]. According to their clinical 
presentation, a specific etiologic diagnosis is essential 
for both therapy and primary prevention. Today, there 
are many vaccines against these infections [3]. It is 
therefore important to estimate the number of vaccine-
preventable illnesses and the impact of the vaccination 
policies implemented.
In 2007 in Italy, the National Institute of Health (Istituto 
Superiore di Sanità, ISS) published a new protocol for 
the National Surveillance of Invasive Diseases caused 
by Neisseria meningitidis, Streptococcus pneumoniae 
and Haemophilus influenzae [4]. The objective was to 
potentiate immunization strategies by improving the no-
tification system of these diseases. Given the availability 
of vaccines to prevent these diseases, a recommendation 
for routine vaccination against Haemophilus influenzae 
type b was introduced into the 1999-2000 National Im-
munization Plan (NIP) [5]. In accordance with the 2005-
2007 NIP [6], which recommends vaccination against 
Neisseria meningitidis serogroup C and Streptococcus 
pneumoniae at the national level only for at-risk groups, 
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the Regional Health Authorities have introduced these 
vaccinations into pediatric immunization schedules; fur-
thermore, some Regional Authorities have adopted ad-
ditional strategies, offering these vaccinations to other 
targets, too [7]. 
We conducted a survey to assess the frequency of inva-
sive diseases, on the basis of the number of notifications, 
and the different immunization strategies in the Italian 
Regions. Furthermore we evaluated the vaccination cov-
erage (VC) in the Local Health Agency 4 “Chiavarese” 
(LHA) in the Liguria Region.
Materials and methods
We obtained data on the frequency of some invasive dis-
eases caused by Haemophilus infleunzae, Neisseria men-
ingitidis and Streptococcus pneumoniae in Italy from the 
report published by the Ministry of Health based on the 
national notifications of infectious diseases databank 
coordinated by the ISS (SIMI) [4]. Furthermore, we ex-
amined regional regulations concerning immunization 
policies [8-13]. Immunization coverage was calculated 
by means of the “OASIS” software (version 9.0.0) used 
in our LHA.
Tab. I. haemophilus influenzae-related diseases (broken down by year and age-class) [4].
Year
Age-class
TOTAL
0 1 - 4 5 - 9 10 - 14 15 - 24 25 - 64 > 64 n.a.
1994 32 41 3 2 1 1 4 2 86 
1995 44 59 6 0 1 4 1 1 116 
1996 46 66 2 4 0 9 1 2 130 
1997 42 43 2 0 2 5 3 2 99 
1998 43 38 3 4 1 4 3 0 96 
1999 26 37 4 0 1 11 5 0 84 
2000 21 17 0 1 2 9 6 1 57 
2001 10 19 2 1 0 10 12 0 54 
2002 9 6 5 2 0 12 4 0 38 
2003 8 8 1 0 0 14 4 0 35 
2004 3 2 2 0 2 6 4 0 19 
2005 2 4 1 1 2 12 8 0 30 
2006 3 2 0 1 0 11 3 0 20 
2007 1 3 0 0 1 13 20 0 38 
2008 2 4 1 2 0 18 22 0 49 
2009 6 3 0 0 1 18 26 0 54 
2010 7 3 1 0 3 28 28 0 70 
2011* 2 1 0 1 2 8 10 0 24 
*partial data
Tab. II. meningococcal-related diseases (broken down by year and age-class) [4].
Year
Age-class
TOTAL
0 1-4 5-9 10-14 15-24 25-64 >64 n.a.
1994 17 42 17 12 28 31 11 6 164 
1995 27 39 18 6 60 40 9 1 200 
1996 27 29 14 13 35 42 8 1 169 
1997 24 39 18 14 39 34 12 2 182 
1998 17 31 24 11 30 33 9 0 155 
1999 34 41 29 17 51 78 25 0 275 
2000 28 41 30 16 58 68 8 1 250 
2001 16 40 23 16 42 50 16 0 203 
2002 22 50 16 11 53 55 9 1 217 
2003 28 56 22 19 59 77 12 4 277 
2004 34 83 27 33 63 90 10 3 343 
2005 31 56 38 18 69 84 27 1 324 
2006 19 35 13 13 28 57 10 4 179 
2007 17 39 15 11 41 46 10 4 183 
2008 22 24 16 18 38 51 11 0 180 
2009 16 36 19 21 37 49 9 0 187 
2010 26 27 18 9 20 40 10 0 150 
2011* 7 12 11 8 21 24 6 0 89 
*partial data
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Results 
Tables I-III show the numbers of notifications of inva-
sive diseases received by the Ministry of Health from 
1994 to 2010. The available data indicated a great re-
duction in Haemophilus influenzae-related diseases in 
the pediatric age. The reduction in Meningococcal dis-
eases caused by all the circulating serogroups in Italy 
proved to be less marked. Diseases caused by Strepto-
coccus pneumoniae seem to have increased since 2007. 
Figure 1 shows variability in the vaccination policies 
against Streptococcus pneumoniae and Neisseria men-
ingitidis serogroup C on the basis of regional regula-
tions concerning the immunization strategies adopted 
in the various Italian Regions. 
Figures 2-4 show vaccination coverage against Haemo-
philus influenzae type b, Pneumococcus, and Meningo-
coccus serogroup C at the 24th month of age in LHA 4 
from 2003 to 2008. Haemophilus influenzae VC was 
95% during the period considered. From 2006 Menin-
gococcal VC was 90% or more. Finally, immunization 
coverage against Streptococcus pneumoniae was 90% 
or more in the last 4 years of the period. Figure 5 shows 
Meningococcal C VC in adolescents (cohorts 1990-
1994): in the cohorts 1992, 1993 and 1994, Meningo-
coccal VC was consistently above 70%.
Discussion
This study presents the number of notifications of inva-
sive diseases collected by the national databank coordi-
nated by the ISS and the current immunization policies 
for anti-Hib, anti-pneumococcal and anti-meningococcal 
C vaccinations adopted in Italian Regions [7]. 
The great reduction in Haemophilus influenzae-related 
diseases in the pediatric age is due to the large-scale vac-
cination policy begun in 1999 in Italy. Prior to the rec-
ommendation for routine vaccination, Hib was the most 
common cause of bacterial meningitis and a major cause 
of other invasive bacterial diseases in Italian children 
(Tab. II). The less marked reduction in Meningococcal 
diseases is due to the fact that vaccination against sero-
group C was introduced more recently (in 2006); further-
more the immunization strategies adopted in the various 
Italian Regions vary (Fig. 1), and vaccination against 
serogroup C is only available in the pediatric age. The 
diseases caused by Streptococcus pneumoniae seem to 
have increased since 2007. This can be ascribed to the 
implementation of the Surveillance of Invasive Diseases 
Program and the subsequent notification of all invasive 
diseases (not only meningitis). Furthermore, the various 
Italian Regions have adopted different immunization 
strategies against this disease, too.
Levels of VC against Haemophilus influenzae are ex-
cellent; the objective indicated in the 2005-2007 NIP 
has therefore been reached. VC against Streptococcus 
pneumoniae and Neisseria meningitidis serogroup C at 
the 24th month of age are also good. However, we need 
to implement specific immunization strategies for ado-
lescents, as VC among these subjects is not completely 
satisfactory. 
Conclusions
The national invasive diseases surveillance system has 
clearly been improved by the introduction of the Spe-
cific Surveillance Program. This has provided better 
information on the size of the problem and the impact 
of immunization strategies on the incidence of invasive 
bacterial diseases. 
Furthermore, immunization policies in Italy display ter-
ritorial heterogeneity, sometimes with differences even 
Tab. III. pneumococcal-related diseases (broken down by year and age-class) [4].
Year
Age-class
TOTAL
0 1 - 4 5 - 9 10 - 14 15 - 24 25 - 64 > 64 n.a.
1994 9 10 3 7 2 42 34 1 108 
1995 14 15 11 3 9 87 37 2 178 
1996 10 15 5 6 6 90 48 2 182 
1997 20 18 9 2 14 97 68 2 230 
1998 19 25 4 7 14 105 82 2 258 
1999 13 22 5 2 13 153 95 3 306 
2000 17 20 6 6 7 124 62 1 243 
2001 16 30 4 4 6 104 65 3 232 
2002 22 24 9 2 6 98 63 4 228 
2003 22 31 7 7 11 120 108 2 308 
2004 19 19 6 3 5 131 112 5 300 
2005 17 25 3 5 7 124 105 4 290 
2006 11 24 8 3 7 111 103 3 270 
2007 22 49 11 6 4 225 202 5 524 
2008 35 63 24 12 8 222 327 0 691 
2009 34 51 18 8 10 276 339 2 738 
2010 29 57 17 11 7 314 413 3 851 
2011* 5 21 6 0 6 97 173 0 308 
*partial data
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Fig. 1. immunization policies for pneumococcal and meningococcal disease,  2011.
Fig. 2. vaccination coverage against haemophilus influenzae type 
b at 24th month in the lha 4 “Chiavarese”.
Fig. 3. vaccination coverage against streptococcus pneumoniae 
at 24th month in the lha 4 “Chiavarese”.
Fig. 4. vaccination coverage against Neisseria meningitidis at 24th 
month in the lha 4 “Chiavarese”.
Fig. 5. vaccination coverage against Neisseria meningitidis at 15th 
year of age in the lha 4 “Chiavarese”.
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within the same Region. Just two months ago, on March, 
the Italian Ministry of Health published the new NIP 
2012-2014, where the vaccinations against Pneumococ-
cus and Meningococcus C are recommended not only 
for risk groups but also for all newborn; the vaccination 
against Meningococcus C is also recommended to ado-
lescents [14]. 
The levels of VC against Haemophilus influenzae, Strep-
tococcus pneumoniae and Neisseria meningitidis at the 
24th month of age in LHA 4 are very high. VC in adoles-
cents (15 year-olds), though good, needs to be improved 
through specific strategies, such as raising the awareness 
of healthcare workers, involving general practitioners 
and educating the target population.
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